Sweet's syndrome with subcutaneous involvement associated with pegfilgrastim treatment: First reported case

Journal of Cutaneous Pathology

Volumn 40, Issue 1, 2013, Pages 46-49

  Llamas Velasco, Mar ^a   García Martín, Patricia ^a   Sánchez Pérez, Javier ^a   Fraga, Javier ^a   García Diez, Amaro ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

granulocyte colony factor; neutrophilic dermatosis; panniculitis

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; NEUTROPENIA; PANNICULITIS; PATHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INJECTIONS, SUBCUTANEOUS; LEUKEMIA, MYELOID, ACUTE; NEUTROPENIA; PANNICULITIS; RECOMBINANT PROTEINS; SWEET SYNDROME;

MLCS; MLOWN;

EID: 84872876567     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12042     Document Type: Article

References (13)

1. Cohen PR,. Subcutaneous Sweet's syndrome: a variant of acute febrile neutrophilic dermatosis that is included in the histopathologic differential diagnosis of neutrophilic panniculitis. J Am Acad Dermatol 2005; 52: 927.
2. Guhl G, Garcia-Diez A,. Subcutaneous Sweet syndrome. Dermatol Clin 2008; 26: 541.
3. Molineux G,. The design and development of pegfilgrastim (PEG-rmetHuG-CSF, Neulasta). Curr Pharm Des 2004; 10: 1235.
4. Florez A, Sanchez-Aguilar D, Roson E, Prieto A, Van den Eyden A, Toribio J,. Sweet's syndrome associated with Salmonella enteritidis infection. Clin Exp Dermatol 1999; 24: 239.
5. Uhara H, Saida T, Nakazawa H, Ito T,. Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor. J Am Acad Dermatol 2008; 59 (2 Suppl. 1): S10.
6. Escallier F, Gaudard S, Courtois JM, Dalac S, Collet E, Lambert D,. Sweet's syndrome and Yersinia enterocolitica infection. Ann Dermatol Venereol 1990; 117: 858.
7. Draper BK, Robbins JB, Stricklin GP,. Bullous Sweet's syndrome in congenital neutropenia: association with pegfilgrastim. J Am Acad Dermatol 2005; 52: 901.
8. White LE, Villa MT, Petronic-Rosic V, Jiang J, Medenica MM,. Pyoderma gangrenosum related to a new granulocyte colony-stimulating factor. Skinmed 2006; 5: 96.
9. Dereure O, Hillaire-Buys D, Guilhou JJ,. Neutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome? Br J Dermatol 2004; 150: 1228.
10. Hasegawa M, Sato S, Nakada M, et al. Sweet's syndrome associated with granulocyte colony-stimulating factor. Eur J Dermatol 1998; 8: 503.
11. Prendiville J, Thiessen P, Mallory SB,. Neutrophilic dermatoses in two children with idiopathic neutropenia: association with granulocyte colony-stimulating factor (G-CSF) therapy. Pediatr Dermatol 2001; 18: 417.
12. Cohen PR, Kurzrock R,. Sweet's syndrome revisited: a review of disease concepts. Int J Dermatol 2003; 42: 761.
13. Rosmaninho A, Lobo I, Selores M,. Sweet's syndrome associated with the intake of a selective cyclooxygenase-2 (COX-2) inhibitor. Cutan Ocul Toxicol 2011; 30: 298.